News

ISHLT leadership is proud to endorse two joint sessions with the Heart Association of the Spanish Society of Cardiology which will be held during the annual congress of the Spanish Heart Failure Association in Zaragoza, Spain on 12 June, 2025.

From among the more than 2,000 presentations in at the Annual Meeting in Boston, three abstracts were selected to receive awards to recognize excellence from early career investigators.

As announced at the ISHLT2025 meeting in Boston last month, Melissa Cousino, PhD, will serve as the Scientific Program Chair for the ISHLT’s 47th Annual Meeting & Scientific Sessions. Dr. Cousino will be the first non-physician ISHLT member to hold this position.

Barostim is a novel device therapy that works with GDMT to targets the neurohormonal pathways responsible for heart failure progression and symptoms. Watch this symposium recording from CVRx to learn more.

ISHLT webinar recordings are open to the entire community any time you need a little extra insight. Watch past recordings and keep an eye on future programs.

First author Peter Cho and senior author Abbas Ardehali, MD, discuss the paper, “Severe primary graft dysfunction in heart transplant recipients using donor hearts after circulatory death: a United States Experience.”

ISHLT en Español llevará a cabo un webinar sobre manejo de infecciones en trasplantes de pulmón y corazón el 4 de junio próximo. El evento es totalmente gratuito y todos son bienvenidos a participar.

All ISHLT members are invited to join Society leaders and fellow members for the ISHLT 2025 Annual Business Meeting—a chance to hear key updates and discuss issues of interest to the ISHLT community on Wednesday 21, May.

Final Day of ISHLT2025

During the final General Session of the ISHLT’s 45th Annual Meeting & Scientific Sessions, ISHLT recognized outstanding achievements in research and groundbreaking scientific contributions.

Tuesday at ISHLT2025

At the ISHLT Annual Meeting in Boston, Dr. Jeffrey Teuteberg showed how molecular testing like cell-free DNA is reducing biopsies, personalizing post-transplant care, and improving outcomes through earlier rejection detection and easier remote monitoring.

Ready for Day Two of ISHLT2025?

At the ISHLT Annual Meeting in Boston, Jitte Jennekens shared that the HOPE technique safely preserves donor lungs outside the body for up to 20 hours. In a study of 12 HOPE cases, all lungs were successfully transplanted with outcomes matching traditional methods, showing promise for extended lung preservation.

At the ISHLT Annual Meeting in Boston, Dr. Angela Lorts stressed the need for pediatric-specific MCS devices, as current adult devices are used off-label for children, leading to safety concerns and supply issues. She introduced the ACTION Network to improve awareness and collaborate on better solutions.

Ten years after its introduction, heart donation after circulatory death (DCD) has significantly boosted transplant rates, with many centers reporting a 30% increase. Proven as effective as traditional methods, DCD is now widely adopted and continues to expand access to life-saving heart transplants.

A talk at the ISHLT2025 Annual Meeting given by Emily Granger, MBBS from St. Vincent’s Hospital in Sydney highlights how machine perfusion technology is revolutionizing heart transplantation in geographically vast countries like Australia.

A groundbreaking collaboration among leading organizations in pediatric heart transplantation has led to the formation of Pediatric Heart Transplant Alliance. Founding partners include Enduring Hearts, ISHLT, PHTS, Transplant Families, ACTION, and Additional Ventures.

At the Opening General Session of the ISHLT2025 Annual Meeting & Scientific Sessions in Boston, ISHLT President Christian Benden unveiled the Society’s new strategic plan.

Welcome to ISHLT2025!